Wed, March 3, 2021
Tue, March 2, 2021
Mon, March 1, 2021

Matthew Harrison Initiated (BOLT) at Buy and Held Target at $45 on, Mar 2nd, 2021

Matthew Harrison of Morgan Stanley, Initiated "Bolt Biotherapeutics, Inc." (BOLT) at Buy and Held Target at $45 on, Mar 2nd, 2021.

Matthew, nor any peers, have made any analyst calls on BOLT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30